Uso de la ortosarcolisina en el mieloma múltiple
Abstract
Se discute la evaluación de la terapéutica en 10 pacientes con mieloma múltiple, describiéndose el resultado obtenido con el uso de la dl-ortosarcolisina. Se vio una buena respuesta con relación a los parámetros clínicos y de laboratorio usados. Las manifestaciones tóxicas no estuvieron presentes, debido al uso racional del medicamento. Las remisiones de la enfermedad fueron más evidentes al inicio de la terapéutica con el medicamento antes mencionado, que en su uso en etapas posteriores. La sobrevivencia obtenida, nos obliga a realizar un estudio más profundo del uso de esta sustancia alquilante en el mieloma múltiple.Downloads
Downloads
Published
How to Cite
Issue
Section
License
The Cuban Journal of Medicine protects the author's patrimonial rights. However, it is licensed under a Creative Commons Licensehttps://creativecommons.org/licenses/by-nc/4.0/deed.es_ES which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided that the primary source of publication is duly cited. The author always retains his moral rights.
You are free to:
- Share - copy and redistribute the material in any medium or format.
- Adapt - remix, transform and build upon the material
- The license cannot revoke these freedoms as long as you follow the terms of the license.
Under the following terms:
- Attribution - You must give proper credit, provide a link to the license, and indicate if changes have been made. You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is supported by the licensor.
- Non-Commercial Purpose- You may not make use of the material for commercial purposes.
- No Additional Restrictions - You may not apply legal terms or technological measures that legally restrict others from making any use permitted by the license.